Berkshire Hathaway Revamps Portfolio 26 Billion Delta Stake and Major Alphabet Increase Sports Ministry Unveils Rules for National Sports Board and Tribunal Lenovo Shares Surge on Record Earnings as AI Revenue Nearly Doubles OpenAI Reportedly Prepares Confidential IPO Filing Signaling AI Market Leadership Southeast Asias Biofuel Push May Strain Food Supplies and Export Capacities US AI Stocks Plunge as Chinas DeepSeek Sparks Market Selloff BBVA Q1 2026 Earnings Earnings Beat Fails to Lift Shares as Revenue Remains Undisclosed INTR Q1 2026 Earnings EPS Falls Short of Estimates Stock Slides 375 OReilly Automotive Inc ORLY Q1 2026 Earnings EPS Beats Estimates by 174 as Stock Edges Higher MRCY Q1 2026 Earnings Massive EPS Beat Drives Stock Higher CODX Q1 2026 Earnings Revenue Remains Elusive as EPS Misses Estimates Stock Surges 53 OXSQG Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short Note Price Holds Steady ARB IOT Group Slips 086 as Stock Nears Key Support at 438 Old National Bancorp Preferred ONBPO Edges Lower Amid Quiet Session Inovio Pharmaceuticals Slips Below 130 as Selling Pressure Intensifies Talon Capital Corp Warrants TLNCW Decline 25 as Selling Pressure Mounts Hagerty HGTY Shares Dip 23 as Trading Activity Remains Focused on Key Support Levels VERAXA Biotech Secures 275M Financing Plans Public Listing via SPAC Merger AFLAC Q1 2026 Earnings EPS Miss Estimates Amid Stable Operations Tradeweb Markets TW Faces Selling Pressure Shares Decline 369 Amid Broader Market Volatility Frankfurt Airport Sky Line Shuttle Breakdown Raises Operational Concerns for New Terminal 3 Spotify Shares Surge After AI Music Partnership with Universal Music Group and Upbeat Guidance AnheuserBusch InBev Shares Decline After Revenue Misses Market Expectations Ryanair Posts Record Annual Profit of 226 Billion Amid Boeing Delays and Fuel Uncertainty IndoStar Capital Reports 130 Crore Annual Profit but Q4 Loss Widens on Security Receipt Provisions UK Exports to US Plunge 25 Following Trump Tariff Blitz Eli Lillys Retatrutide Gains Attention Following CNBC Report on Phase 3 Data